UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 79

Sortiert nach

Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson’s disease

Journal of neurology, 2016-05, Vol.263 (5), p.895-905

2016

Link zum Volltext

Verfügbarkeit prüfen

Autonomic dysfunction in parkinsonian LRRK2 mutation carriers

Parkinsonism & related disorders, 2013-10, Vol.19 (10), p.906-909

2013

Link zum Volltext

Verfügbarkeit prüfen

Outcome of bilateral deep brain subthalamic stimulation in patients carrying the R1441G mutation in the LRRK2 dardarin gene

Neurosurgery, 2008-04, Vol.62 (4), p.857-863

2008

Link zum Volltext

Verfügbarkeit prüfen

Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain

Parkinsonism & related disorders, 2007-12, Vol.13 (8), p.509-515

2007

Link zum Volltext

Verfügbarkeit prüfen

Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain

Neurogenetics, 2009-10, Vol.10 (4), p.347-353

2009

Link zum Volltext

Verfügbarkeit prüfen

The new mutation, E46K, of α-synuclein causes parkinson and Lewy body dementia

Annals of neurology, 2004-02, Vol.55 (2), p.164-173

2004

Link zum Volltext

Verfügbarkeit prüfen

Exploring Genetic Factors Involved in Huntington Disease Age of Onset: E2F2 as a New Potential Modifier Gene

PloS one, 2015-07, Vol.10 (7), p.e0131573-e0131573

2015

Link zum Volltext

Verfügbarkeit prüfen

Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program

Parkinsonism & related disorders, 2015-10, Vol.21 (10), p.1133-1144

2015

Link zum Volltext

Verfügbarkeit prüfen

Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson’s disease

Journal of neurology, 2011-03, Vol.258 (3), p.494-499

2011

Link zum Volltext

Verfügbarkeit prüfen

Complicaciones del tratamiento en la enfermedad de Parkinson. Las fluctuaciones con síntomas no motores

Revista de neurologiá, 2010-05, Vol.50 (S04), p.43

Lezcano García, Elena

2010

Link zum Volltext

Verfügbarkeit prüfen

Bomba de apomorfina: inconvenientes

Revista de neurologiá, 2010-01, Vol.50 (S01), p.49

Lezcano García, Elena

2010

Link zum Volltext

Verfügbarkeit prüfen

Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene

Parkinsonism & related disorders, 2015-05, Vol.21 (5), p.494-499

2015

Link zum Volltext

Verfügbarkeit prüfen

Nocturnal hypertension and dysautonomia in patients with Parkinson’s disease: are they related?

Journal of neurology, 2013-07, Vol.260 (7), p.1752-1756

2013

Link zum Volltext

Verfügbarkeit prüfen

Initial neuropsychological impairments in patients with the E46K mutation of the α-synuclein gene (PARK 1)

Journal of the neurological sciences, 2011-11, Vol.310 (1), p.86-89

2011

Link zum Volltext

Verfügbarkeit prüfen

Restless legs syndrome in Parkinson's disease

Movement disorders, 2007-10, Vol.22 (13), p.1912-1916

2007

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of pallidal stimulation in primary dystonia: results of the Spanish multicentric study

Journal of neurology, neurosurgery and psychiatry, 2010-01, Vol.81 (1), p.65-69

2010

Link zum Volltext

Verfügbarkeit prüfen

Impulse control and repetitive behaviors in Parkinson's disease — Are there differences in the relation to dopamine agonist treatment?

Journal of the neurological sciences, 2014-10, Vol.345 (1), p.252-253

2014

Link zum Volltext

Verfügbarkeit prüfen

Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations

Parkinsonism & related disorders, 2015-07, Vol.21 (7), p.717-722

2015

Link zum Volltext

Verfügbarkeit prüfen

The applause sign and neuropsychological profile in progressive supranuclear palsy and Parkinson's disease

Clinical neurology and neurosurgery, 2013-08, Vol.115 (8), p.1230-1233

2013

Link zum Volltext

Verfügbarkeit prüfen

Cardiac sympathetic denervation in symptomatic and asymptomatic carriers of the E46K mutation in the α synuclein gene

Parkinsonism & related disorders, 2013-01, Vol.19 (1), p.95-100

2013

Link zum Volltext

Verfügbarkeit prüfen

Initial neuropsychological impairments in patients with the E46K mutation of the [alpha]-synuclein gene (PARK 1)

Journal of the neurological sciences, 2011-11, Vol.310 (1-2), p.86-89

2011

Link zum Volltext

Verfügbarkeit prüfen

SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy

Parkinsonism & related disorders, 2012-01, Vol.18 (1), p.45-48

2012

Link zum Volltext

Verfügbarkeit prüfen

Initial neuropsychological impairments in patients with the E46K mutation of the α-synuclein gene (PARK 1): Proceeding of the 7th International Congress on Mental Dysfunction and other Non-Motor Features in Parkinson's Disease Related Disorders, Barcelona, Spain, 9-12 December, 2010

Journal of the neurological sciences, 2011, Vol.310 (1-2), p.86-89

2011

Link zum Volltext

Verfügbarkeit prüfen

Relationship between sleep and dysautonomic symptoms assessed by self-report scales

Movement disorders, 2011-08, Vol.26 (10), p.1967-1968

2011

Link zum Volltext

Verfügbarkeit prüfen

Sleep complaints and their relation with drug treatment in patients suffering from Parkinson's disease

Movement disorders, 2006-07, Vol.21 (7), p.983-988

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(79)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson’s disease

Autonomic dysfunction in parkinsonian LRRK2 mutation carriers

Outcome of bilateral deep brain subthalamic stimulation in patients carrying the R1441G mutation in the LRRK2 dardarin gene

Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain

Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain

The new mutation, E46K, of α-synuclein causes parkinson and Lewy body dementia

Exploring Genetic Factors Involved in Huntington Disease Age of Onset: E2F2 as a New Potential Modifier Gene

Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program

Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson’s disease

Complicaciones del tratamiento en la enfermedad de Parkinson. Las fluctuaciones con síntomas no motores

Bomba de apomorfina: inconvenientes

Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene

Nocturnal hypertension and dysautonomia in patients with Parkinson’s disease: are they related?

Initial neuropsychological impairments in patients with the E46K mutation of the α-synuclein gene (PARK 1)

Restless legs syndrome in Parkinson's disease

Efficacy and safety of pallidal stimulation in primary dystonia: results of the Spanish multicentric study

Impulse control and repetitive behaviors in Parkinson's disease — Are there differences in the relation to dopamine agonist treatment?

Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations

The applause sign and neuropsychological profile in progressive supranuclear palsy and Parkinson's disease

Cardiac sympathetic denervation in symptomatic and asymptomatic carriers of the E46K mutation in the α synuclein gene

Initial neuropsychological impairments in patients with the E46K mutation of the [alpha]-synuclein gene (PARK 1)

SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy

Initial neuropsychological impairments in patients with the E46K mutation of the α-synuclein gene (PARK 1): Proceeding of the 7th International Congress on Mental Dysfunction and other Non-Motor Features in Parkinson's Disease Related Disorders, Barcelona, Spain, 9-12 December, 2010

Relationship between sleep and dysautonomic symptoms assessed by self-report scales

Sleep complaints and their relation with drug treatment in patients suffering from Parkinson's disease

Suchergebnisse filtern